JXSL1900063 | Guselkumab注射液 | guselkumab | Injection | Biological Products | Import Drug Application | 2019-07-22 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2019-07-19 | view |
JYSB2000051 | Guselkumab注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-02-24 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2020-02-22 | view |
JXSS1900035 | Guselkumab注射液 | guselkumab | Injection | Biological Products | Import Drug Application | 2019-06-22 | Janssen-Cilag International NV | Janssen-Cilag International NV | Certificate Issued | 2019-12-31 | view |
JXSB2000044 | Guselkumab注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-12-10 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2020-12-09 | view |
JYSB2000007 | Guselkumab注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-01-16 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2020-01-15 | view |
JYSB2000114 | Guselkumab注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-04-13 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2020-04-11 | view |
JXSB2000011 | Guselkumab注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-09-07 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2020-09-04 | view |
JXSL1800039 | Guselkumab注射液 | guselkumab | Injection | Biological Products | Import Drug Application | 2018-10-26 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2018-10-25 | view |
JXHL1200301 | Ibrutinib胶囊 | ibrutinib | Capsule | Chemical Drugs | Import Drug Application | 2012-10-10 | Janssen-Cilag International NV | Janssen-Cilag International NV | Certificate Issued | 2013-04-17 | view |
JXHL1200229 | Ibrutinib胶囊 | ibrutinib | Capsule | Chemical Drugs | Import Drug Application | 2012-08-06 | Janssen-Cilag International NV | Janssen-Cilag International NV | Certificate Issued | 2013-04-17 | view |
JXHL1300050 | Ibrutinib胶囊 | ibrutinib | Capsule | Chemical Drugs | Import Drug Application | 2013-02-25 | Janssen-Cilag International NV | Janssen-Cilag International NV | Certificate Issued | 2013-10-12 | view |
JXHL1300335 | Ibrutinib胶囊 | ibrutinib | Capsule | Chemical Drugs | Import Drug Application | 2013-09-06 | Janssen-Cilag International NV | Janssen-Cilag International NV | Certificate Issued | 2014-08-11 | view |
JXSL1800015 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Import Drug Application | 2018-06-13 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2018-06-12 | view |
JXSS1900027 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Import Drug Application | 2019-06-03 | Janssen-Cilag International NV | Janssen-Cilag International NV | Certificate Issued | 2020-03-12 | view |
JXSL1800037 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Import Drug Application | 2018-10-22 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2018-10-20 | view |
JYSB1800102 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Supplementary Application | 2018-05-10 | Janssen-Cilag International NV | Janssen-Cilag International NV | Filed | 2018-05-22 | view |
JYSB2000490 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Supplementary Application | 2020-09-30 | Janssen-Cilag International NV | Janssen-Cilag International NV | Filed | 2020-10-30 | view |
JYSB1800275 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Supplementary Application | 2018-12-27 | Janssen-Cilag International NV | Janssen-Cilag International NV | Certificate Issued | 2019-02-27 | view |
JYSB2000583 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Supplementary Application | 2020-11-28 | Janssen-Cilag International NV | Janssen-Cilag International NV | In Review | 2020-11-27 | view |
JYSB1900112 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Supplementary Application | 2019-05-10 | Janssen-Cilag International NV | Janssen-Cilag International NV | Filed | 2019-05-24 | view |